Related Experiment Videos
Cyclic neutropenia terminating in permanent agranulocytosis
1Department of Internal Medicine and Haematology, Aalborg Hospital, Denmark.
Acta Medica Scandinavica
|January 1, 1988
Summary
A patient with cyclic neutropenia developed permanent agranulocytosis. Treatments like prednisone, lithium, and apheresis did not increase neutrophil counts, highlighting a challenging clinical scenario.
Area of Science:
- Hematology
- Immunology
Background:
- Cyclic neutropenia is a rare blood disorder characterized by periodic drops in neutrophil count.
- Understanding the progression of neutropenia is crucial for patient management.
Observation:
- A patient diagnosed with cyclic neutropenia was monitored for two decades.
- After 16 years, the patient transitioned to permanent agranulocytosis, lacking neutrophils for four years.
Findings:
- Standard treatments including prednisone, lithium, and apheresis (leukapheresis and plasmapheresis) were ineffective in restoring neutrophil levels.
- The case demonstrates a severe, refractory form of neutropenia unresponsive to common interventions.
Implications:
- This case highlights the limitations of current therapies for advanced neutropenia.
- Further research into novel treatment strategies for agranulocytosis is warranted.
- The long-term survival without neutrophils presents a unique clinical challenge.